Iatrogenic comorbidity in childhood and adolescence

New insights from the use of antidepressant drugs

Emanuela Offidani, Giovanni A. Fava, Nicoletta Sonino

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The term "iatrogenic comorbidity" refers to unfavorable modifications in the course of an illness, with regard to its characteristics and responsiveness, which may be related to previous treatments. Some iatrogenic adverse events arising from either pharmacotherapy or psychotherapy cannot be subsumed under the traditional rubric of adverse effects and require careful evaluation. Children and adolescents are generally more likely to experience adverse health consequences after drug treatment. The use of antidepressant drugs in this age group may cause potential long-term detrimental effects, such as mood elevation that does not subside when drugs are discontinued and may predispose to the development of a bipolar disorder. The concept of iatrogenic comorbidity in children and adolescents has heuristic value in weighing potential benefits and risks associated particularly with psychotropic treatments.

Original languageEnglish (US)
Pages (from-to)769-774
Number of pages6
JournalCNS Drugs
Volume28
Issue number9
DOIs
StatePublished - Jan 1 2014

Fingerprint

Antidepressive Agents
Comorbidity
Bipolar Disorder
Psychotherapy
Pharmaceutical Preparations
Therapeutics
Age Groups
Drug Therapy
Health
Heuristics

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Clinical Neurology
  • Medicine(all)

Cite this

Offidani, Emanuela ; Fava, Giovanni A. ; Sonino, Nicoletta. / Iatrogenic comorbidity in childhood and adolescence : New insights from the use of antidepressant drugs. In: CNS Drugs. 2014 ; Vol. 28, No. 9. pp. 769-774.
@article{31497aea191e4134af25319b1d2c46d0,
title = "Iatrogenic comorbidity in childhood and adolescence: New insights from the use of antidepressant drugs",
abstract = "The term {"}iatrogenic comorbidity{"} refers to unfavorable modifications in the course of an illness, with regard to its characteristics and responsiveness, which may be related to previous treatments. Some iatrogenic adverse events arising from either pharmacotherapy or psychotherapy cannot be subsumed under the traditional rubric of adverse effects and require careful evaluation. Children and adolescents are generally more likely to experience adverse health consequences after drug treatment. The use of antidepressant drugs in this age group may cause potential long-term detrimental effects, such as mood elevation that does not subside when drugs are discontinued and may predispose to the development of a bipolar disorder. The concept of iatrogenic comorbidity in children and adolescents has heuristic value in weighing potential benefits and risks associated particularly with psychotropic treatments.",
author = "Emanuela Offidani and Fava, {Giovanni A.} and Nicoletta Sonino",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s40263-014-0184-0",
language = "English (US)",
volume = "28",
pages = "769--774",
journal = "CNS Drugs",
issn = "1172-7047",
publisher = "Adis International Ltd",
number = "9",

}

Iatrogenic comorbidity in childhood and adolescence : New insights from the use of antidepressant drugs. / Offidani, Emanuela; Fava, Giovanni A.; Sonino, Nicoletta.

In: CNS Drugs, Vol. 28, No. 9, 01.01.2014, p. 769-774.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Iatrogenic comorbidity in childhood and adolescence

T2 - New insights from the use of antidepressant drugs

AU - Offidani, Emanuela

AU - Fava, Giovanni A.

AU - Sonino, Nicoletta

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The term "iatrogenic comorbidity" refers to unfavorable modifications in the course of an illness, with regard to its characteristics and responsiveness, which may be related to previous treatments. Some iatrogenic adverse events arising from either pharmacotherapy or psychotherapy cannot be subsumed under the traditional rubric of adverse effects and require careful evaluation. Children and adolescents are generally more likely to experience adverse health consequences after drug treatment. The use of antidepressant drugs in this age group may cause potential long-term detrimental effects, such as mood elevation that does not subside when drugs are discontinued and may predispose to the development of a bipolar disorder. The concept of iatrogenic comorbidity in children and adolescents has heuristic value in weighing potential benefits and risks associated particularly with psychotropic treatments.

AB - The term "iatrogenic comorbidity" refers to unfavorable modifications in the course of an illness, with regard to its characteristics and responsiveness, which may be related to previous treatments. Some iatrogenic adverse events arising from either pharmacotherapy or psychotherapy cannot be subsumed under the traditional rubric of adverse effects and require careful evaluation. Children and adolescents are generally more likely to experience adverse health consequences after drug treatment. The use of antidepressant drugs in this age group may cause potential long-term detrimental effects, such as mood elevation that does not subside when drugs are discontinued and may predispose to the development of a bipolar disorder. The concept of iatrogenic comorbidity in children and adolescents has heuristic value in weighing potential benefits and risks associated particularly with psychotropic treatments.

UR - http://www.scopus.com/inward/record.url?scp=84929130906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929130906&partnerID=8YFLogxK

U2 - 10.1007/s40263-014-0184-0

DO - 10.1007/s40263-014-0184-0

M3 - Article

VL - 28

SP - 769

EP - 774

JO - CNS Drugs

JF - CNS Drugs

SN - 1172-7047

IS - 9

ER -